These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1912106)

  • 1. Plasma phenylethylamine in schizophrenic patients.
    O'Reilly R; Davis BA; Durden DA; Thorpe L; Machnee H; Boulton AA
    Biol Psychiatry; 1991 Jul; 30(2):145-50. PubMed ID: 1912106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma phenylethylamine and phenylalanine in chronic schizophrenic patients.
    Szymanski HV; Naylor EW; Karoum F
    Biol Psychiatry; 1987 Feb; 22(2):194-8. PubMed ID: 3814669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cross-cultural study of a biochemical abnormality in paranoid schizophrenia.
    Jeste DV; Doongaji DR; Panjwani D; Datta M; Potkin SG; Karoum F; Thatte S; Sheth AS; Apte JS; Wyatt RJ
    Psychiatry Res; 1981 Dec; 5(3):341-52. PubMed ID: 6948314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma serine in schizophrenics and controls measured by gas chromatography-mass spectrometry.
    Baruah S; Waziri R; Hegwood TS; Mallis LM
    Psychiatry Res; 1991 Jun; 37(3):261-70. PubMed ID: 1679949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in plasma homovanillic acid concentrations in schizophrenic patients following neuroleptic discontinuation.
    Davidson M; Kahn RS; Powchik P; Warne P; Losonczy MF; Kaminsky R; Apter S; Jaff S; Davis KL
    Arch Gen Psychiatry; 1991 Jan; 48(1):73-6. PubMed ID: 1670618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenylethylamine and phenylacetic acid in CSF of schizophrenics and healthy controls.
    Beckmann H; Reynolds GP; Sandler M; Waldmeier P; Lauber J; Riederer P; Gattaz WF
    Arch Psychiatr Nervenkr (1970); 1983; 232(6):463-71. PubMed ID: 6134517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of cannabis abuse on schizophrenic psychopathology.
    Peralta V; Cuesta MJ
    Acta Psychiatr Scand; 1992 Feb; 85(2):127-30. PubMed ID: 1543037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences between paranoid and nonparanoid schizophrenic patients on the somatosensory P300 event-related potential.
    Louzã MR; Maurer K
    Neuropsychobiology; 1989; 21(2):59-66. PubMed ID: 2615924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma homovanillic acid differences in clinical subgroups of first episode schizophrenic patients.
    Baeza I; Castro-Fornieles J; Deulofeu R; de la Serna E; Goti J; Salvà J; Bernardo M
    Psychiatry Res; 2009 Jul; 168(2):110-8. PubMed ID: 19501918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The dexamethasone suppression test and negative symptoms of schizophrenia.
    McGauley GA; Aldridge CR; Fahy TA; Eastment C
    Acta Psychiatr Scand; 1989 Dec; 80(6):548-53. PubMed ID: 2618777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone response to clonidine in neuroleptic-free patients with multidagnostically defined schizophrenia.
    Keks NA; Copolov DL; McKenzie DP; Kulkarni J; Hassett A; Matheson B; Hill C; Mackie B; Singh B; Hirt J
    Psychiatry Res; 1993 Jul; 48(1):79-90. PubMed ID: 8416019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subtypes of schizophrenia--evidence from a twin-family study.
    Onstad S; Skre I; Torgersen S; Kringlen E
    Acta Psychiatr Scand; 1991 Aug; 84(2):203-6. PubMed ID: 1950618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced total antioxidant level and increased oxidative stress in patients with deficit schizophrenia: a preliminary study.
    Albayrak Y; Ünsal C; Beyazyüz M; Ünal A; Kuloğlu M
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():144-9. PubMed ID: 23657077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Empirical evaluation of the factorial structure of clinical symptoms in schizophrenia: effects of typical neuroleptics on the brief psychiatric rating scale.
    Harvey PD; Davidson M; White L; Keefe RS; Hirschowitz J; Mohs RC; Davis KL
    Biol Psychiatry; 1996 Oct; 40(8):755-60. PubMed ID: 8894068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Free and conjugated plasma homovanillic acid in schizophrenic patients.
    Garcia A; Galinowski A; Guicheney P; Mignot E; Loo H; Meyer P
    Biol Psychiatry; 1989 May; 26(1):87-96. PubMed ID: 2720023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gender differences in onset of illness, treatment response, course, and biologic indexes in first-episode schizophrenic patients.
    Szymanski S; Lieberman JA; Alvir JM; Mayerhoff D; Loebel A; Geisler S; Chakos M; Koreen A; Jody D; Kane J
    Am J Psychiatry; 1995 May; 152(5):698-703. PubMed ID: 7726309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concentrations of beta-phenylethylamine in plasma and plateletes of schizophrenics.
    Myojin T; Taga C; Tsuji M
    Jpn J Psychiatry Neurol; 1989 Jun; 43(2):171-6. PubMed ID: 2796027
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Validity of specific subscales of the positive and negative symptom scales in older schizophrenia outpatients.
    McAdams LA; Harris MJ; Heaton SC; Bailey A; Fell R; Jeste DV
    Schizophr Res; 1997 Oct; 27(2-3):219-26. PubMed ID: 9416651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma glycine and serine levels in schizophrenia compared to normal controls and major depression: relation to negative symptoms.
    Sumiyoshi T; Anil AE; Jin D; Jayathilake K; Lee M; Meltzer HY
    Int J Neuropsychopharmacol; 2004 Mar; 7(1):1-8. PubMed ID: 14720317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Self-rating scales in schizophrenia: validity assessment of the Paranoid-Depression Scale (PD-S), the Frankfurt Self-feeling Scale (FBS) and of two visual analogy scales].
    Schaeffer E; Wciórka J
    Psychiatr Pol; 2003; 37(2):293-314. PubMed ID: 12776660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.